Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: Clinical observation of efficacy and predictors of prognostic factors

National Medical Journal of China

Volumn 91, Issue 31, 2011, Pages 2190-2194

  Fan, Wen Zhe ^a   Yang, Jian Yong ^a   Lü, Ming De ^a   Xie, Xiao Yan ^a   Yin, Xiao Yu ^a   Huang, Yong Hui ^a   Kuang, Ming ^a   Li, He Ping ^a   Xu, Hui Xiong ^a   Li, Jia Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Catheter ablation; Radiology, interventional

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; HUMAN; LIVER CELL CARCINOMA; MICROWAVE THERAPY; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME; ADOLESCENT; ADULT; AGED; CATHETER ABLATION; CLINICAL TRIAL; FEMALE; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870454455     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.31.008     Document Type: Article

References (16)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55: 74-108.
2. 2003, 83: 1053-1057.
3. Ikai I, Arii S, Okazaki M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res, 2007, 37: 676-691.
4. Meng MB, Cui YL, Lu Y, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol, 2009, 92: 184-194.
5. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002, 35: 1164-1171.
6. Ueno K, Miyazono N, Inoue H, et al. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer, 2000, 88: 1574-1581.
7. Marin-Hargreaves G, Azoulay D, Bismuth H, et al. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol, 2003, 47: 13-27.
8. 2006, 86: 801-805.
9. Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol, 2005, 40: 1054-1060.
10. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 2002, 359: 1734-1739.
11. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology, 2000, 214: 761-768.
12. Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma. Cancer, 2009, 115: 1914-1923.
13. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 2006, 16: 661-669.
14. Peng ZW, Chen MS, Liang HH, et al. A case-control study comparing percutaneous radiofrequency ablation aloneor combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol, 2009, 36: 257-263.
15. Qian J, Truebenbach J, Graepler F, et al. Application of poly-lactide-coglycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol 2003, 9: 94-98.
16. Choi JW, Park JY, Ahn SH, et al. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection. Am J Clin Oncol, 2009, 32: 564-569.